Key result
Continuous subcutaneous insulin infusion rapidly reduces elevated urinary albumin excretion in long-term type 1 diabetes.
Answers are grounded in this paper and cite their sources.
To study the effects of improved control of blood glucose on markers of renal glomerular and tubular function, we initially determined, by radioimmunoassay technics, urinary excretion rates of albumin and beta2 microglobulin in 17 nondiabetic subjects and in 43 insulin-dependent, clinically nonproteinuric diabetic patients. Duration of diabetes ranged from six months to 39 years, and the patients were studied while receiving conventional therapy. Mean urinary albumin excretion was significantly elevated in the diabetics, but beta2-microglobulin excretion rates were not different from those of the controls, suggesting that the increased albumin excretion was due to increased transglomerular loss of albumin. Seven patients with long-term diabetes (duration of six to 33 years), selected because of elevated albumin excretion, were studied before and during a continuous, subcutaneous insulin infusion for a period of one to three days. Urinary albumin excretion was significantly reduced during the insulin infusion, but mean beta2-microglobulin excretion did not change. Strict control of blood glucose, even in the short term, may reverse a functional renal abnormality in long-duration, insulin-dependent diabetes.
No takes yet. Share an insight, caveat, or question.
Viberti et al. (1979) studied Insulin-dependent diabetes (n=60). Continuous subcutaneous insulin infusion vs. Conventional therapy (pre-infusion baseline) and nondiabetic controls was evaluated on Urinary excretion rates of albumin and beta2-microglobulin. Continuous subcutaneous insulin infusion for 1 to 3 days significantly reduced elevated urinary albumin excretion in 7 long-term insulin-dependent diabetic patients without changing beta2-microglobulin.
Synapse has enriched 10 related papers. Consider them for comparative context: